Guidance Offered to Help Doctors Deal With 'Dr. Google'

Share this content:
Guidance Offered to Help Doctors Deal With 'Dr. Google'
Guidance Offered to Help Doctors Deal With 'Dr. Google'

TUESDAY, May 12, 2015 (HealthDay News) -- Good communication is the key to resolving conflicts between the tests and treatment a patient may want based on online searches and those a physician believes are necessary, according to an article published online in Medical Economics.

Noting that many patients will have obtained health-related information from the Internet before visiting their physician, the article discusses how to deal with conflicts between patients and physicians with respect to unnecessary testing.

The article notes that physicians should listen to patients and acknowledge their concerns, being attentive to underlying emotions. Physicians may resist or resent 'Dr. Google,' as patients come with misinformation and preconceived ideas about their diagnosis or treatment. However, the trend toward online research accompanies the growing emphasis on patient engagement; even after doing research online, patients need the expertise of the provider to navigate valid information. When a patient requests an unnecessary test, it's important to deal with the motivation for their desire for the test; conversely, when a patient objects to a test, it's important to respect a patient's autonomy.

"There's always the possibility that a patient could leave a provider's office and say, 'I did not get what I wanted,'" Larry Brown, M.D., from the CHI Health Alegent Creighton Clinic in Omaha, Neb., explains in the article. "But there should never be a situation where they weren't listened to and a clear diagnostic process was put in place."

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths